Yellow fever vaccine. Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2002.
This report updates CDC's recommendations for using yellow fever vaccine (CDC. Yellow Fever Vaccine: Recommendations of the Advisory Committee on Immunizations Practices: MMWR 1990;39[No. RR-6]1-6). The 2002 recommendations include new or updated information regarding 1) reports of yellow fever vaccine-associated viscerotropic disease (previously reported as febrile multiple organ system failure); 2) use ofyellow fever vaccine for pregnant women and persons infected with human immunodeficiency virus (HIV); and 3) concurrent use of yellow fever vaccine with other vaccines. A link to this report and other information related to yellow fever can be accessed at the website for Travelers' Health, Division of Global Migration and Quarantine, National Center for Infectious Diseases, CDC, at http://www.cdc.gov/travel/index.htm, and through the website for the Division of Vector-Borne Infectious Diseases, National Center for Infectious Diseases, CDC, at http://www.cdc.gov/ncidod/ dvbid/yellowfever/index.htm.
Cetron
Martin S
MS
Division of Global Migration and Quarantine, National Center for Infectious Diseases, CDC, USA.
Marfin
Anthony A
AA
Julian
Kathleen G
KG
Gubler
Duane J
DJ
Sharp
Donald J
DJ
Barwick
Rachel S
RS
Weld
Leisa H
LH
Chen
Robert
R
Clover
Richard D
RD
Deseda-Tous
Jaime
J
Marchessault
Victor
V
Offit
Paul A
PA
Monath
Thomas P
TP
D000293:Adolescent; D000328:Adult; D000368:Aged; D002648:Child; D002675:Child, Preschool; D000075202:Contraindications; D005260:Female; D006801:Humans; D006967:Hypersensitivity; D016867:Immunocompromised Host; D007223:Infant; D008297:Male; D008875:Middle Aged; D011247:Pregnancy; D014195:Travel; D014611:Vaccination / Q000592:standards*; D015004:Yellow Fever / Q000517:prevention & control*; D022341:Yellow Fever Vaccine / Q000008:administration & dosage* / Q000009:adverse effects
D022341:Yellow Fever Vaccine